BiotechTube
Home/Renovion/Carolyn Durham, PhD
CD

Carolyn Durham, PhD

Chief Scientific Officer

Renovion

Therapeutic Areas

PulmonologyTransplant Medicine

Renovion Pipeline

DrugIndicationPhase
ARINA-1 (RVN-301)Non-Cystic Fibrosis Bronchiectasis (NCFBE)Phase 2

Leadership Team at Renovion

DC
Dan Copeland
Chief Executive Officer
MZ
Marty Zamora, MD
Chief Medical Officer
MT
Marilyn Thompson
Head of Finance
HC
Hal Craig
Head of Chemistry, Manufacturing, and Controls Strategy and Operations
DW
Derek Winstanly, MBChB
Chairman of the Board
View full Renovion profile